| Serial Number | 99371566 |
| Word Mark | TLB |
| Filing Date | Wednesday, September 3, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, April 1, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Pseudo Mark | TIANLI BIOTECH |
| Description of Mark | The mark consists of a design of square with rounded corners, inside with two circles separated by a curved line resembling a stylized percentage symbol, below with the stylized letters “TLB”. |
| Goods and Services | Inhalers for medical purposes, sold empty; Oxygen inhalers for medical purposes sold empty; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of asthma, respiratory diseases; Nebulizers for medical purposes; Nebulizers for respiration therapy; Respirators for filtering air for medical purposes; Medical instruments for analysing and identifying bacteria; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic instruments for the analysis of body fluids; Medical diagnostic apparatus for testing for viruses |
| Goods and Services | Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for treating respiratory diseases; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of idiopathic pulmonary fibrosis (IPF); Biochemical reagents for medical or veterinary purposes; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment and prevention of pulmonary fibrosis (PF); Inhalants for the treatment of asthma; Biological reagents for medical purposes; none of the foregoing relating to cosmetics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 3, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 3, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Tianli Biotech Pty Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 81 - NOT AVAILABLE |
| Address | WHEELERS HILL VIC 3150 AU |
| Event Date | Event Description |
| Wednesday, September 3, 2025 | NEW APPLICATION ENTERED |
| Wednesday, September 3, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, January 22, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 22, 2026 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, January 23, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, January 28, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 28, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 28, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 30, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 30, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 1, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |